Clinical Trial Update: Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating nivolumab with or without relatlimab before chemoradiation in patients with gastric or esophageal cancers; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Relatlimab (relatlimab)
• nivolumab (Opdivo) (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Gastric Cancer, Esophageal Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING